Respirology

Article	Citations
Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry	143
Environmental plastics and lung health: Increasing evidence for concern	122
Issue Information	102
Holding our breath: Exploring the causes of hypercapnic respiratory failure resulting in mortality	85
Mind the gaps: Occupational and environmental exposures in interstitial lung diseases	77
Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient	60
Leading Women in Respiratory Clinical Sciences: Letter From Hong Kong	57
Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates	49
Friend or foe? Corticosteroids in sarcoidosis	48
Letter from Croatia	46
Home monitoring to detect progression of interstitial lung disease: A prospective cohort study	44
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	43
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?	43
Targeting vasculature to reduce fetal growth restriction associated bronchopulmonary dysplasia	41
Issue Information	38
The challenge of minimizing tuberculosis burden in people living with HIV in the Asia Pacific	38
Issue Information	38
Are we coming out from the COVID‐19 pandemic?	38
Issue Information	37
Another line of defence	37
Diagnosing OSA in primary care: The utility of clinical judgement, screening questionnaires and portable monitoring	35
Proposed novel treatment paradigm of aberrant gait and balance kinematics in patients with severe COPD	33
Letter from Turkey: Impact of COVID‐19 on respiratory diseases	33
Letter from Thailand	32
Issue Information	31

	31
Ubi pus, ibi evacua: Optimizing intrapleural fibrinolytic therapy in pleural infections	31
Impact of COVID‐19 pandemic restrictions on the cardio‐respiratory health of New Zealanders	30
Cardiovascular and cerebrovascular mortality in patients with preceding asthma exacerbation	29
Let us start thinking about what to do in the event of a global influenza pandemic	28
	28
Is there a role for chest wall mobilization in the management of COPD?	27
Letter from Malta	27
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	27
Protection of Vulnerable Workers: An Imperative for All	26
Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE‐BUILD) pilot study	26
World Lung Day 2023—Access to prevention and treatment for all, leave no one behind	26
P9‐6: Establishment of a human severe asthma model using humanized mice	24
P9‐30: Increase in fev1 after dupilumab treatment for refractory asthma is associated with post‐treatment eosinophilia	24
P10‐9: The role of long‐term continuous positive airway pressure in the progression of obstructive sleep apnea: A longitudinal cohort study	24
Bayesian adaptive clinical trial designs for respiratory medicine	24
P14‐9: Lung function analysis of COVID‐19 survivors in dr. Zainoel Abidin Hospital Banda Aceh, Indonesia	23
P10‐12: Risk factors for poor sleep quality and excessive daytime sleepiness in late pregnancy: A preliminary analysis of a cross‐sectional survey	23
P16‐10: Usefulness of plasma and urine lysophospholipids‐producing enzymes as a prognostic marker for sarcoidosis	23
P12‐7: Preoperative chest CT localization under different positions with appropriate amount of air in the pleural space for the evaluation of bullae related to spontaneous pneumothorax	23
P16‐59: Clinical significance of serum heart‐type fatty acid‐binding protein (H‐FABP) in acute exacerbation of idiopathic interstitial pneumonias	22
P16‐61: Development of improved method to identify and analyze lung fibrocytes with flow cytometry in a reporter mouse strain	22
P16‐77: Factors associated with interstitial lung disease in patients with rheumatoid arthritis (RA‐ILD): Experience from a rheumatology‐respiratory centre in Malaysia	21
P16‐37: Effect of autophagy in human alveolar epithelial cells on pulmonary fibrosis	21
P16‐80: Differential source of early phase discontinuation between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis	21
P16‐64: Safety of immune checkpoint inhibitors in advanced non‐small cell lung cancer patients with interstitial lung abnormalities or interstitial lung disease	21
P5‐7: Phagocytotic analysis of alveolar macrophage phenotypes in patients with Mycobacterium avium complex lung disease	20
Improving support of informal carers of respiratory patients	20
COVID‐19 hospitalizations: Another adverse impact of ambient air pollution?	20
P1‐47: Clinical characteristics of severe COVID19 patients	20
P4‐27: Correlation between smoking habit and factors that determines smoking habit in male college students in Depok	20
P16‐108: When you lose the way, history leads it!	20
P8‐22: Solo surgery style. benefits and technical points of robot‐assisted respiratory surgery	18
P9‐16: High serum EDN levels may be a predictive biomarker for the responsiveness of benralizumab treatment	18
O18‐5: Sleep apnea and academic performance: A study on medical students using the Berlin questionnaire	17
P8‐109: Prognostic impact and efficacy of neutrophil‐to‐lymphocyte ratio (NLR) in patients with malignant mesothelioma	17
P8‐15: Usefulness of liquid biopsy for patients with non‐small cell lung cancer harboring an EGFR mutation treated with afatinib	17
O17‐2: Performance of GINA score against ACT in defining asthma control and predicting unplanned healthcare utilization	16
P16‐93: Preliminary analysis of serum risk factors during an acute exacerbation of chronic fibrosing interstitial pneumonia: A multi‐institutional prospective study	16
P2‐18: Establishment of acquired pemetrexed‐resistant MPM cell lines and evaluation of an IGF‐1R inhibitor picropodophyllin for MPM treatment	16
P4‐14: Hydrofluorocarbons pneumonitis as a complication of inhalation injury following air‐conditioning repairs	15
P9‐38: The time course of type 2 biomarkers in asthmatics treated with dupilumab	15
P5‐152: Familial ciclesonide‐responsive cases of COVID‐19 pneumonia	15
P9‐34: Seasonal dynamics of cold airway hyperresponsiveness in asthma patients	15
P2‐45: Porphyromonas gingivalis enhances pneumococcal adhesion to human alveolar epithelial cells by increasing expression of host platelet‐activating factor receptor	15
O5‐5: Current smoking by socioeconomic status in a representative Japanese population	15
O9‐2: Gut microbiota signature can distinguish latent TB infection among poorly diabetic patients	15
O11‐1: Siglec‐1‐negative alveolar macrophages are associated with COPD exacerbation and may represent pro‐inflammatory phenotypes	14
P1‐35: A case of chronic type II respiratory failure due to Bethlem myopathy	14
P5‐73: Clinical characteristics of pulmonary melioidosis diagnosed at respiratory Department of the Tertiary Hospital in Southern Vietnam	14

P9‐27: Clinical feature and effectiveness of benralizumab therapy for severe asthma	14
O3‐6: The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements	14
P5‐121: Inhaled beclomethasone in the treatment of early COVID‐19: A placebo‐controlled, randomized trial	14
P5‐32: Investigation of exacerbation factors in patients with coronavirus disease 2019	13
P4‐13: Assessment of the impact of atmospheric air microsuspensions on the respiratory function of patients with chronic obstructive pulmonary disease	13
P5‐80: A case report of pneumothorax associated with COVID‐19 pneumoniae	13
O14‐3: Diagnostic and dynamic circulating methylated DNA markers for non‐small cell lung cancer	13
P6‐27: Intrapleural alteplase and DNase for complex tuberculous pleural effusion	13
P12‐4: Interventional pulmonology for elderly patients with malignant central airway obstruction	13
P9‐33: A study of severe asthma patients who continued omalizumab treatment for more than 3 years	13
P5‐101: A case report of COVID‐19 in an adult filipino with HIV‐associated histoplasmosis	13
P5‐157: Adverse event following COVID‐19 vaccination and antibody titers in pulmonologists and pulmonology residents	13
P11‐1: The therapeutic effects of lactoferrin on thioacetamide‐induced liver fibrosis in rats	13
P8‐49: Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small cell lung cancer	12
P8‐89: Carcinoid tumors of lung – Diagnosis, treatment and outcomes in a tertiary care centre, INDIA	12
P5‐55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?	12
P5‐47: Safety and efficacy of remdesivir, baricitinib and high‐dose steroid combination therapy in patients hospitalized with COVID‐19	12
P7‐37: The characteristics of responders to treatment with tiotropium/olodaterol: A large cohort post‐marketing surveillance post‐hoc analysis in Japan	12
P1‐15: Chest X‐ray improvement in COVID‐19 moderate symptoms with remdesvir and favipiravir: A comparative study	12
P6‐36: Components system of nitric oxide as markers of pulmonary multi‐drug resistant tuberculosis process activity	12
P5‐52: Evaluation of the luminex xTAG respiratory viral panel fast v2 assay for rapid diagnosis of respiratory viral infections	12
P4‐2: Mite allergen avoidance decreases allergic symptoms in children in Ishinomaki City after natural disasters	12
P1‐3: Prescribing oxygen: An audit of prescribing and delivery practices at two tertiary hospitals in Melbourne, Australia	11
P9‐61: Resolvin E3 dampens asthmatic inflammation in a murine model	11
P5‐36: Association of C‐reactive protein (CRP), serum ferritin, and patient outcome in COVID‐19 patients in tertiary referral hospital	11
P9‐81: A case of mepolizumab‐tolerant allergic bronchopulmonary aspergillosis successfully switching to benralizumab	10
P9‐9: Functional activation of human eosinophils by acetylcholine	10
P16‐28: CD38+ HLA‐DR− helper T lymphocytes are associated with immune checkpoint inhibitors‐related interstitial pneumonia	10
P9‐65: Analysis of anti‐inflammatory effects of Resolvin E3 and its deoxy derivatives	10
P12‐10: Additional use of propofol during flexible bronchoscopy in difficult‐to‐sedate cases with transcutaneous blood gas monitoring, anesthetized with midazolam and fentanyl: A retrospective study	10
P1‐88: Persistent bilateral unprovoked pulmonary embolism ‐ A case of chronic thromboembolic pulmonary hypertension in a young lady with seronegative antiphospholipid syndrome	10
P8‐148: A case of recurrent respiratory papillomatosis with malignant transformation in a young Filipino female presenting as multiple pulmonary nodules	10
P8‐20: Postoperative radiotherapy prolongs survival of completely resected Masaoka/Masaoka‐Koga stage II/III thymoma	10
P8‐76: Loss of glutathione S‐transferase omega 2 caused by DNA hypermethylation is associated with progression of non‐small cell lung cancer	10
P1‐73: Dry needling and orthopnoea: A case of bilateral, atraumatic phrenic nerve demyelination	9
P6‐35: The predicament in diagnosing Mycobacterium tuberculosis in young patients	9
P16‐65: Relationship between size and morphology of alveolar macrophages in bronchoalveolar lavage fluid in sarcoidosis	9
P16‐29: The attempt to establish the disease prognosis prediction model using Charlson Comorbidity Index Score in interstitial lung disease	9
P5‐102: Chronic pulmonary melioidosis in a 9 year old child	9
P1‐82: Successful treatment of bilateral diaphragmatic paralysis from HIV associated axonal polyneuropathy with bilevel positive airway pressure ‐ A case report	9
P16‐70: Clinical value of 18F‐FDG PET/CT For acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease after lung resection	9
P16‐18: Role of IGF‐1 in idiopathic pulmonary fibrosis: analysis of patient lung specimens	9
P1‐93: A case of lung mass with bifurcation that was difficult to differentiate from lung cancer	9
P16‐35: Lung infiltration of immunoglobulin g1‐ and G4‐positive cells is a prognostic marker for idiopathic interstitial pneumonias	9
P1‐5: The cytokine balance of allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA)	9
P5‐145: COVID‐19: Performance of oseltamivir and isoprinosine in neutrophil‐to‐lymphocyte ratio improvement from confirmed COVID‐19 patients in Saiful Anwar General Hospital, Malang	9
P14‐1: Long‐acting muscarinic antagonists enhance ciliary function in airway epithelium	9
P16‐72: Effects of nintedanib on forced vital capacity categorical changes and disease progression in Japanese patients with progressive fibrosing interstitial lung diseases: subanalysis of inbuild st	9
P6‐10: Mysterious nodule in the spermatic cord in an immunosuppressed patient – An executive's agony	9
P5‐109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID‐19 patient	9
P5‐99: The successful of intrapleural alteplase and pulmozyme in treating rhodococcus empyema in an immunocompromised patient	8
P16‐20: Database analysis of hypersensitivity pneumonitis in Japan	8
P6‐28: Clinical case of using intravenous forms of anti‐tuberculosis drugs to improve the treatment efficiency of tuberculosis in patients with malabsorption syndrome (MS)	8
P8‐150: Real world study of afatinib and erlotinib as firstline therapy of positive EGFR mutation Javanese lung adenocarcinoma	8
P1‐66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report	8
P5‐125: Abrupt cessation of systemic corticosteroid in coronavirus disease 19 (COVID‐19) related secondary organizing pneumonia resulted in a rebound	8
P1‐54: Paclitaxel impedes g1 phase progression in gefitinib‐resistant non‐small‐cell lung cancer	8
P8‐39: Current status and future challenges of lung cancer genomic medicine at Hiroshima University Hospital	8
P8‐26: Study of the number of courses required for the first response to immune checkpoint inhibitor (+chemo) therapy for lung cancer	8
P6‐47: Adverse drug reactions and their impact on the treatment of pulmonary tuberculosis in elderly patients	8
P7‐65: Correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD)	8
P8‐24: The miR‐124‐3P/ZFP36L1 axis is suppressed by ASCL1 in lung adenocarcinoma	8
P8‐5: Quantification of visible her family dimers by proximity ligation assay and its clinical evaluation in non‐small cell lung cancer patients treated with EGFR‐TKI	8
P9‐36: Aspergillus sensitization in bronchial asthma; a single centre study in Sri Lanka	7
P9‐85: The reaction of the pituitary‐adrenal system to cold bronchoprovocation in asthma patients with subclinical hypothyroidism	7
O20‐1: Spinal cord infarction after bronchial artery embolization using coils for hemoptysis: A single‐center retrospective analysis of 3046 procedures	7
P12‐21: The recommended image features of peripheral lung parenchymal targets for diagnosis by CT‐guided needle biopsy	7
P9‐42: Impact of an asthma shared care service on hospital attendances and admissions	7
O25‐5: The end of the road for patients with interstitial lung disease, are we doing enough?	7
P16‐2: Development and assessment of the efficacy and safety of human lung‐targeting liposomal methylprednisolone crosslinked with nanobody	7
P11‐3: The risk of suicide in critical illness patients‐ the known, the unknown, and the unknowable	7
O3‐5: Fast AI‐enabled cell tracking and migration analysis for high‐throughput drug screening	6
O13‐3: The ratio of T790M to EGFR‐activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR‐TKI‐refractory NSCLC	6
P11‐8: Surviving covid: A case report on the first covid survivor after extracorporeal membrane oxygenation (ECMO) in the Philippines	6
P15‐1: Risk assessment in pulmonary hypertension due to interstitial lung disease	6
P8‐112: Clinical laboratory result as prognosis marker in advanced stage non‐small cell lung cancer (NSCLC) in Indonesia	6
P10‐15: The importance of polysomnography screening in bariatric surgery. Sheikh Khaliah Medical City Experience	6
P9‐72: Development and pilot testing of AsmaBoleh: A mobile application to identify the risk factors of asthma attack among Malaysian adults	6
P5‐29: Fungal hydro‐pneumothoraces! A series of patients presenting with hydro‐pneumothoraces secondary to invasive fungal infection and a review of literature regarding the same	6
P9‐60: Successful treatment with benralizumab for asthma with eosinophilic myocarditis	6

P16‐21: Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease; a multicenter retrospective cohort study	6
P10‐13: CIH can induce liver macrophage M2 polarization	6
P9‐73: Effects of dupilumab for severe eosinophilic asthma COPD overlap	6
P16‐75: Traction bronchiectasis on conventional chest computed tomography is a prognostic factor for rheumatoid arthritis‐related interstitial lung disease	6
O1‐3: Lung volume recruitment therapy in people with neuromuscular disease	6
O20‐4: Diagnostic yield and the number of tumor cells of ultrathin bronchoscopy for peripheral lung lesions: A comparison with thin bronchoscopy	6
P9‐63: Prevalence and clinical relevance of pertussis infection in adult patients with asthma	6
P15‐15: A rare case of bilateral chylothorax and chylous ascites in diffuse large beta cell non‐hodgkin's lymphoma	6
P16‐54: Association between efficacy of antifibrotic agents and immunohistochemical localization of fibrotic factors in progressive fibrosing interstitial lung disease	6
P9‐28: A comparison of clinical characteristics, between severe asthmatics who continued omalizumab administration and those underwent switch to other biologic agents	6
P1‐89: Postural herniation of a skeletal muscle hemangioma through intercostal space	6
P8‐114: Impact of clinical features on two‐year survival in T790M mutant NSCLC treated with osimertinib	5
P6‐17: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis (MTB) identification in patients with pulmonary tuberculosis	5
P8‐137: Association of immune‐related adverse events with therapeutic response to nivolumab in patients with malignant pleural mesothelioma	5
P4‐28: Case series: High flow nasal cannula in carbon monoxide intoxication	5
P16‐84: The relationship between the treatment dose and survival of patients with interstitial pneumonia treated with pirfenidone	5
P8‐177: Chest wall Ewing's sarcoma – A diagnostic and therapeutic adventure	5
P2‐48: Correlation between MGAT4a and MGAT5 expression and poorer outcome in advanced lung adenocarcinoma	5
P9‐56: Frequency of biologics use for the treatment of severe asthma in six hospitals in Kanagawa, Japan: A retrospective multi‐center retrospective analysis	5
P5‐130: Scrub typhus complicated with pneumonitis and myocarditis; potentially a fatal complication	5
P8‐23: Clinical importance of LINC00460 expression in EGFR mutation‐positive lung cancer treated with osimertinib	5
P8‐82: CD8‐positive peripheral T cell lymphoma in a patient following long‐term nivolumab for advanced lung adenocarcinoma: A case report	5
P9‐70: The effect of inhalation instruction with wearing masks on therapeutic effect	5
P4‐15: A clinical research of heated tobacco products users in our smoking cessation clinic	5
P5‐43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID‐19 pneumonia in pregnancy	5
P16‐58: Low BMI is associated with poor prognosis in patients with IPF who were incidentally diagnosed	5
P5‐97: High‐dose methylprednisolone in combination with tocilizumab in hospitalized patients with critical COVID‐19 pneumonia: A case series	5
P7‐47: Blood eosinophil count as a predictive biomarker of COPD exacerbation in a real‐world setting	5
P1‐16: VAP bundle for chronic ventilator ward patients in TB and chest unit of Grantham Hospital	5
P8‐44: Predictive biomarker for the therapeutic effect of PD‐L1 inhibitor maintenance therapy in patients with extensive‐stage small‐cell lung cancer	5
P9‐83: Assessing peak inspiratory flow rate of patients on dry powdered inhalers using training kits and the in‐check dial G16 inspiratory flow meter	5
O12‐2: Effectiveness of empirical anti‐pseudomonal antibiotics in recurrent COPD exacerbation: A multicenter retrospective cohort study	5
P16‐89: Comparison of clinical features between the high and low serum KL‐6 patients with acute exacerbation of interstitial lung diseases	5
P7‐64: Comparative effectiveness of glycopyrronium monotherapy vs ICS/LABA in drug‐naïve mild‐moderate COPD patients: A real world experience from INDIA	5
P16‐112: A case of pulmonary langerhans cell histiocytosis (PLCH) presenting as massive hemoptysis	4
P5‐66: Withdrawn	4
P5‐46: Myocardial injury association with severity of disease in hospitalized COVID‐19 patients	4
O2‐3: Novel non‐invasive point of care sputum test for early identification of Pseudomonas aeruginosa airway infection	4
P2‐57: The periodontopathic bacterium Fusobacterium nucleatum induced proinflammatory cytokine production by human respiratory epithelial cell lines and in the lower respiratory organs in mice	4
O10‐4: Effectiveness of intravenous isoniazid and ethambutol administration in patients with drug‐susceptible pulmonary tuberculosis with TB‐meningoencephalitis and HIV co‐infection in the intensive p	4
P16‐116: Elusive lung adenocarcinoma in systemic sclerosis with non specific interstitial pneumonia	4
P8‐188: The inhibitory effect of pemetrexed disodium heptahydrate on the growth of KRAS‐dependent A549 cells	4
P1‐63: Respiratory responses during two minutes walking in late‐stage elderly people	4
O18‐1: Information‐motivation‐behavioral skills intervention increases the CPAP adherence in old OSAHS patients	4
P2‐5: TGF‐Β‐induced epithelial‐mesenchymal transition and tumor‐promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma	4
O17‐5: Soluble TIM‐4 levels in serum are associated with severe asthma phenotype	4
P5‐8: Risk factors for mortality of COVID‐19 confirmed cases admitted at lung center of the Philippines	4
P2‐50: TLR3 signaling induces IFITM1 expression via IFN‐B and ISG56 in cultured BEAS‐2B bronchial epithelial cells	4
O19‐4: Pilot mobile assisted ventilation services (MOVES) in acute general medical wards (AGMW) during winter surge in QEH	4
P8‐83: Giant pleuro parenchymal metastases from a rare primary tumor	4
O18‐3: Analysis of nocturnal desaturation waveform by using algorithm in the patients with idiopathic pulmonary fibrosis	4
P11‐14: Blood gas analysis and alveolar‐arterial gradient as predictor of mortality confirmed COVID‐19 patients outcome in Tertiary Referral Hospital	4
P1‐7: Withdrawn	4
P16‐95: High incidence of MPO‐ANCA positive interstitial pneumonia during the COVID‐19 pandemic	4
Erratum	4
O21‐4: A case report of bronchiolitis obliterans in a child post hydrocarbon inhalation in Angkor Hospital for Children	4
O16‐5: Asthma persistence is associated with gender, age and inhaled corticosteroid treatment and history of disease exacerbations in Chinese children	4
P5‐6: A convenient risk prediction score for COVID‐19 in determining whether hospitalization should be recommended: Kanagawa admission priority assessment score (KAPAS)	4
O5‐4: The effects of smoking cessation therapy on pulmonary function and predictive factor of the FEV1 increase	4
O22‐4: Dynamic‐forced expiratory CT as a useful protocol for severe ECAC	4
P1‐68: Association between smoking and physical fitness measured using 6‐minutes walking test in nonstaff employee University of Indonesia, Depok: A cross‐sectional study	4
P4‐5: Withdrawn	4
Why we still need drugs for COVID‐19 and can't just rely on vaccines	3
Association Between the Visceral Fat‐to‐Muscle Ratio and Severe Exacerbation of COPD: A Prospective Cohort Study	3
Intergenerational trauma and long‐term lung dysfunction: Early life exposures and pulmonary function in Indigenous Australian adults	3
Factors associated with 6‐min walk distance in severe asthma: A cross‐sectional study	3
Bronchial provocation testing: Should we look beyond FEV1?	3
Small babies at birth, small lungs for life?	3
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	3
Leading women pulmonologists in India: Beacons of change	3
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	3
Decline in respiratory and cardiac admissions during the COVID‐19 pandemic: What is the role of common respiratory virus infections?	3
Leading women in respiratory medicine: Letter from Indonesia	3
Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association	3
O8‐4: Determination of antibody titers of filipino healthcare workers after COVID‐19 vaccination (Sinovac and Astrazenica) ‐ A preliminary report	3
Bronchoscopic approaches to sampling lung nodules: Aiming for the bulls eye	3
Home sweet home… or is it?	3
The big 5 respiratory diseases give insight into respiratory health and beyond	3
Guidelines? Nice if you can afford it	3
Epilogue to contemporary perspectives in COPD: New Horizons	3
NLR in CBC: A holy grail for biomarker research in COPD?	3
	3
Into the meaning of Respirology, Pulmonology and Pneumology	3
Assessing obstructive sleep apnoea by oxygen desaturation metrics: Pre‐dawn clearing	3
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology	3
Letter from Nepal	3
Omics technologies to study virus infection and chronic lung diseases	3
Recommendations from the Medical Education Editor	3
Stirring the publishing pot by ending accept/reject decisions	3
Longitudinal changes in total and regional body composition in patients with chronic obstructive pulmonary disease	3
Initiating home non‐invasive ventilation: How well are we doing?	3
Quantitative comparison of dose–effect and time–course of fluticasone furoate and fluticasone propionate in adult and adolescent patients with persistent asthma: A systematic review and meta‐analysis	3
O5‐2: Factors affecting compliance to COVID‐19 infection prevention and control measures and its effects on the risk of COVID‐19 infection among physicians in a tertiary government hospital	3
Is it time to use HFNC oxygen therapy during exercise in IPF patients?	3
Language concordance in healthcare: Beyond just talk	3